Radiofrequency ablation of needle tract seeding in hepatocellular carcinoma

被引：21

作者：

Espinoza, S ^{[1
]}

Briggs, P ^{[1
]}

Duret, JS ^{[1
]}

Lapeyre, M ^{[1
]}

de Baère, T ^{[1
]}

机构：

[1] Inst Gustave Roussy, Dept Intervent Radiol, Serv Pr Roche, F-94800 Villejuif, France

来源：

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2005年 / 16卷 / 05期

关键词：

D O I：

10.1097/01.RVT.0000153109.56827.70

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A tumor needle tract seeding, 20 mm in diameter, was detected with magnetic resonance (MR) imaging in a 72-year-old man, 10 months after radiofrequency ablation of a 55-mm subcapsular hepatocellular carcinoma. This seeding was successfully treated with ultrasound-guided percutaneous radiofrequency ablation. No recurrence was found after a 2-year follow-up either on contrast-enhanced computed tomography or MR imaging. Needle tract seeding treatment is not well established. Percutaneous radiofrequency ablation of such seeding is one elegant potential treatment option. Efficacy seems promising but has to be confirmed in larger series. Further evaluation is needed.

引用

页码：743 / 746

页数：4

共 15 条

[1] Long-term follow-up after neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma [J].

Arrivé, L ;

Vurgait, A ;

Monnier-Cholley, L ;

Lewin, M ;

Balladur, P ;

Poupon, R ;

Tubiana, JM .

EUROPEAN RADIOLOGY, 2002, 12 (01) :74-76

[2]

Bolondi L, 2001, HEPATOLOGY, V34, P608, DOI 10.1053/jhep.2001.27952

[3] Radio frequency ablation of renal cell carcinoma: Preliminary clinical experience [J].

de Baere, T ;

Kuoch, V ;

Smayra, T ;

Dromain, C ;

Cabrera, T ;

Court, B ;

Roche, A .

JOURNAL OF UROLOGY, 2002, 167 (05) :1961-1964

[4] Adverse events during radiofrequency treatment of 582 hepatic tumors [J].

de Baère, T ;

Risse, O ;

Kuoch, V ;

Dromain, C ;

Sengel, C ;

Smayra, T ;

El Din, MG ;

Letoublon, C ;

Elias, D .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (03) :695-700

[5] Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors [J].

Gervais, DA ;

McGovern, F ;

Arellano, RS ;

McDougal, WS ;

Mueller, PR .

RADIOLOGY, 2003, 226 (02) :417-424

[6] Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation [J].

Hori, T ;

Nagata, K ;

Hasuike, S ;

Onaga, M ;

Motoda, M ;

Moriuchi, A ;

Iwakiri, H ;

Uto, H ;

Kato, J ;

Ido, A ;

Hayashi, K ;

Tsubouchi, H .

JOURNAL OF GASTROENTEROLOGY, 2003, 38 (10) :977-981

[7]

Ishii H, 1998, CANCER, V82, P1638, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1638::AID-CNCR7>3.3.CO

[8]

2-O

[9] Radiofrequency ablation for hepatocellular carcinoma: Help or hazard? [J].

Kato, T ;

Reddy, KR .

HEPATOLOGY, 2001, 33 (05) :1336-1337

[10] Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study [J].

Livraghi, T ;

Solbiati, L ;

Meloni, MF ;

Gazelle, GS ;

Halpern, EF ;

Goldberg, SN .

RADIOLOGY, 2003, 226 (02) :441-451

← 1 2 →